Abstract | BACKGROUND: OBJECTIVES: SETTINGS: Tertiary intensive care unit. PATIENTS: METHODS: RESULTS: The two groups of patients were comparable for mean age (55 years for IHD vs. 60 years for CVVHDF; NS) and number of failing organs prior to therapy (mean of 4.2 for IHD vs. 3.7 for CVVHDF; NS). Severity of illness at admission as assessed by APACHE II score, however, was greater for patients receiving CVVHDF (29.4 vs 25.7; p<0.003). CVVHDF was associated with a significantly lower plasma urea (p < 0.0001) and serum creatinine (p < 0.01) level at 24 hours of treatment despite similar levels at the start of therapy Throughout the duration of therapy, mean urea levels (35.0 mmol/L for IHD vs 23.4 mmol/L for CVVHDF) and mean serum creatinine levels (513 micromoles/L for IHD and 263 micromoles/L for CVVHDF) showed significantly (p <0.0001) better control of uremia with CRRT. CONCLUSIONS:
|
Authors | R Bellomo, M Farmer, S Bhonagiri, S Porceddu, M Ariens, D M'Pisi, C Ronco |
Journal | The International journal of artificial organs
(Int J Artif Organs)
Vol. 22
Issue 3
Pg. 145-50
(Mar 1999)
ISSN: 0391-3988 [Print] United States |
PMID | 10357242
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Topics |
- Acute Kidney Injury
(complications, diagnosis, mortality, therapy)
- Adult
- Aged
- Female
- Follow-Up Studies
- Hemodiafiltration
(methods, mortality)
- Humans
- Intensive Care Units
- Kidney Function Tests
- Male
- Middle Aged
- Multiple Organ Failure
(complications)
- Peritoneal Dialysis, Continuous Ambulatory
(methods, mortality)
- Renal Dialysis
(methods, mortality)
- Severity of Illness Index
- Statistics, Nonparametric
- Survival Rate
- Treatment Outcome
- Uremia
(complications, prevention & control)
|